IL6 and rheumatoid arthritis: Therefore, high TNFα and/or type I IFN-related gene expressions in peripheral blood and/or synovium at baseline might suggest a better response to anti-TNFα or anti-IL6 treatments in RA patients, while low expression of type I IFN-response genes suggests a better response to anti-B cell therapy in RA patients.